SCHEMBL2895158

SCHEMBL2895158

CCOC(=O)Cn1ncc(Cl)c(Cl)c1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 14/20 0.61
HTT P42858 14/20 0.61
NPC1 O15118 8/20 0.61
SMN1; SMN2 Q16637 8/20 0.61
MITF O75030 8/20 0.61
RAB9A P51151 11/20 0.60
NPSR1 Q6W5P4 8/20 0.60
MAPT P10636 8/20 0.60
S1PR4 O95977 5/20 0.60
S1PR1 P21453 5/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
PAX8 Q06710 2/20 0.60
POLB P06746 4/20 0.56
LMNA P02545 10/20 0.55
S1PR2 O95136 3/20 0.55
HCRTR1 O43613 1/20 0.55
CYP1A2 P05177 1/20 0.55
HSP90AA1 P07900 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29451328 0.88 MEN1 (0.51) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL10815353 0.86 MEN1 (0.49) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL29451993 0.86 ALDH1A1 (0.53) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL24779602 0.85 ALDH1A1 (0.64) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL29452222 0.85 MEN1 (0.48) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL29451899 0.83 MEN1 (0.47) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL13024307 0.83 SMN1; SMN2 (0.50) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL29451719 0.82 MEN1 (0.46) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL29451882 0.82 MEN1 (0.46) ALDH1A1HTTNPC1SMN1; SMN2MITF
SCHEMBL29451976 0.82 MEN1 (0.46) ALDH1A1HTTNPC1SMN1; SMN2MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022032144-A1 SUBSTRATE ADAPTOR INHIBITORS OF PRMT5 AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2022-02-10 WO disclosed
US-8440666-B2 Pyridazinone compounds and P2X7 receptor inhibitors NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2013-05-14 US disclosed
US-20100286390-A1 PYRIDAZINONE COMPOUNDS AND P2X7 RECEPTOR INHIBITORS NISSAN CHEMICAL INDUSTRIES LIMITED 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286390-A1 PYRIDAZINONE COMPOUNDS AND P2X7 RECEPTOR INHIBITORS P2RY1, P2RX7, P2RX1 ALDH1A1 2584/4885HTT 4503/4885NPC1 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.